Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).

Area of Science:

• Neuroscience
• Psychiatry
• Radiology

Background:

• Obsessive-compulsive disorder (OCD) is a debilitating mental health condition.
• The serotonin system is implicated in the pathophysiology of OCD.
• In vivo imaging can assess neurochemical deficits in psychiatric disorders.

Purpose of the Study:

• To investigate the availability of brain serotonin transporters in drug-free OCD patients.
• To compare serotonin transporter availability between OCD patients and healthy controls.
• To evaluate the role of serotonin transporter deficits in OCD.

Main Methods:

• Single-photon emission computed tomography (SPECT) was used with the radioligand [(123)I]beta-CIT.
• Serotonin transporter availability was quantified using binding ratios in specific brain regions (thalamus/hypothalamus, midbrain, brainstem).
• Regions of interest (ROI) analysis compared OCD patients (n=10) with age-matched healthy controls.

Main Results:

• Significantly reduced specific to non-specific [(123)I]beta-CIT binding ratios were observed in the midbrain and brainstem of OCD patients compared to controls.
• Mean ratios in the midbrain were 3.51 (OCD) vs. 4.89 (controls).
• Mean ratios in the brainstem were 2.38 (OCD) vs. 3.53 (controls).

Conclusions:

• In vivo findings demonstrate reduced serotonin transporter availability in the midbrain and brainstem of OCD patients.
• This supports the serotonin deficit hypothesis of obsessive-compulsive disorder.
• Further research into serotonin system modulation for OCD treatment is warranted.